CITI/CALL/ABBOTT LABORATORIES/180/0.1/20.06.24 Share Price

Warrant

DE000KG56QL6

Delayed Deutsche Boerse AG 04:37:12 18/06/2024 pm IST
0.001 EUR 0.00% Intraday chart for CITI/CALL/ABBOTT LABORATORIES/180/0.1/20.06.24
Date Price Change
18/24/18 0.001 0.00%
17/24/17 0.001 0.00%
14/24/14 0.001 0.00%
13/24/13 0.001 0.00%
12/24/12 0.001 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 18, 2024 at 04:37 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Citi Citi
WKN KG56QL
ISINDE000KG56QL6
Date issued 05/07/2022
Strike 180 $
Maturity 20/06/2024 (3 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.24
Lowest since issue 0.001

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.4 USD
Average target price
125.4 USD
Spread / Average Target
+21.19%
Consensus